John Heymach, MD, PhD, Discusses the Use of Adjuvant Immunotherapy for Patients With NSCLC
July 23rd 2021CancerNetwork® sat down with John Heymach, MD, PhD, at the 2021 American Society of Clinical Oncology Annual Meeting to talk adjuvant immunotherapy for recurrence-free survival in resected non–small cell lung cancer.